Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Evotec, Active Biotech Ink Screening Pact
Mar 2010
HAMBURG, Germany, March 22, 2010 – Evotec AG announced it has entered into a collaboration with Active Biotech AB to identify small-molecule modulators of a priority biological target, selected by the latter company, involved in immune disorders and cancer.

The former company, a novel small-molecule drugs discovery and development company, will use its technologies in assay development, high-throughput screening and surface plasmon resonance screening for the identification and validation of novel hits. It will screen its Lead Discovery Library, a small-molecule collection, to maximize the probability of finding medicinal chemistry starting points.

Active Biotech, of Lund, Sweden, is an autoimmune and inflammatory diseases and cancer biotechnology company.

For more information, visit:

See acousto-optic modulator; electro-optic modulator.
Calculated quantity of the entire longitudinal wave of a solid substance's electron gas.
Active BiotechautoimmuneBasic Sciencebiological targetBiophotonicsbiotechnologyBusinesscancercollaborationdrug discoveryEuropeEvotecEvotec AGGermanyhigh-throughput screeningimmune disorderinflammatoryLead Discovery Librarymedicinal chemistrymodulatormoleculeplasmonscreeningsmall molecule drugssurface plasmon resonanceSweden

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.